-
<![CDATA[New Therapies Targeting OX40 Pathway Offer Hope for Atopic Dermatitis | Fall Clinical Derm 2025]]>
25 Oct 2025 03:53 GMT
… (OX40L) signaling pathway for atopic dermatitis (AD). The pathway plays a …
-
<![CDATA[INTEGUMENT: Quality of Life with Roflumilast Cream (Zoryve) in Atopic Dermatitis]]>
25 Oct 2025 00:52 GMT
… and older with atopic dermatitis significantly, with particular improvements … those impacted by atopic dermatitis, including young children and … mild-to-moderate atopic dermatitis. These data also … Global Assessment for Atopic Dermatitis (vIGA-AD3) score of …
-
<![CDATA[Mobile App Enables Accurate Remote Assessment of Atopic Dermatitis]]>
24 Oct 2025 23:38 GMT
… remotely track and assess atopic dermatitis (AD) was successful.1 The … F, et al. Monitoring atopic dermatitis using mobile-app based photography … caring for patients with atopic dermatitis: a randomized controlled cost-effectiveness …
-
<![CDATA[ADjoin: Phase 3 Findings Released on Lebrikizumab (Ebglyss) for Atopic Dermatitis]]>
24 Oct 2025 18:57 GMT
… moderate-to-severe atopic dermatitis results in durable disease … using lebrikizumab in atopic dermatitis. The data were the … the pathogenesis of atopic dermatitis, promoting type-2 inflammation … underestimated cytokine in atopic dermatitis. Allergy. 2020;75( …
-
Eli Lilly's New Ebglyss Results Back Flexible Treatment Options For Atopic Dermatitis
24 Oct 2025 17:01 GMT
… ) for moderate-to-severe atopic dermatitis.
Ebglyss showed sustained similar levels …
-
Eli Lilly achieves positive results for a reduced-dose treatment for atopic dermatitis
24 Oct 2025 16:20 GMT
… ) for moderate to severe atopic dermatitis maintained similar levels of skin …
-
<![CDATA[Challenges With Topical Treatments in Pediatric Atopic Dermatitis]]>
24 Oct 2025 13:44 GMT
… managing extensive atopic dermatitis coverage on their … treatments.
Patients with atopic dermatitis affecting sensitive areas like … , children with atopic dermatitis still face unmet medical … who develop severe atopic dermatitis present the greatest challenge …
-
<![CDATA[Nonsteroidal Options in Pediatric Atopic Dermatitis]]>
24 Oct 2025 13:44 GMT
Patients with atopic dermatitis benefit most from comprehensive treatment …
-
Arcutis to Present New Quality of Life and Long-Term Data with ZORYVE® (roflumilast) Cream 0.15% and 0.05% for the Treatment of Atopic Dermatitis at the Fall Clinical Dermatology Conference
24 Oct 2025 12:00 GMT
… signs and symptoms of atopic dermatitis, and maintained or increased … inflammatory dermatoses combined—atopic dermatitis, seborrheic dermatitis, and plaque psoriasis. ZORYVE … for atopic dermatitis, plaque psoriasis, and seborrheic dermatitis to win …
-
<![CDATA[Atopic Dermatitis Treatment Breaks: Impact of Intermittent Topical Therapy on Pediatric Patient Outcomes]]>
22 Oct 2025 10:13 GMT
Managing chronic atopic dermatitis, especially in children, requires a … systemic treatments. Understanding that atopic dermatitis is an autoimmune, chronic disease … of patients living with atopic dermatitis.